Pear Therapeutics (PEARW) Stock Analysis

What Pear Therapeutics does

Pear Therapeutics, Inc. specializes in the creation and market introduction of software-driven medical therapies. The company boasts a growing portfolio of digital products and candidates, primarily addressing severe psychiatric and neurological conditions. Notable offerings include PearConnect, a dedicated support hub for users of its prescription digital therapeutics; reSET, designed to manage substance use disorder; reSET-O, specifically for opioid use disorder; and Somryst, an intervention for chronic insomnia. This enterprise, founded in 2013, operates from its headquarters in Boston, Massachusetts.

Key metrics

ETFs linked to PEARW

Broad-market and Healthcare sector ETFs an investor holding Pear Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PEARW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Pear Therapeutics?

Pear Therapeutics trades under the ticker PEARW on NASDAQ.

Which exchange is PEARW listed on?

PEARW is listed on NASDAQ.

What sector does Pear Therapeutics operate in?

Pear Therapeutics is classified in the Healthcare sector (Medical - Healthcare Information Services industry).

How can PortView help analyze PEARW in a portfolio?

PortView shows PEARW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.